1587 related articles for article (PubMed ID: 36039144)
1. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.
Younossi Z; Aggarwal P; Shrestha I; Fernandes J; Johansen P; Augusto M; Nair S
JHEP Rep; 2022 Sep; 4(9):100525. PubMed ID: 36039144
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis.
McSweeney L; Breckons M; Fattakhova G; Oluboyede Y; Vale L; Ternent L; Balp MM; Doward L; Brass CA; Beyer F; Sanyal A; Anstee QM
JHEP Rep; 2020 Jun; 2(3):100099. PubMed ID: 32435754
[TBL] [Abstract][Full Text] [Related]
3. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study.
O'Hara J; Finnegan A; Dhillon H; Ruiz-Casas L; Pedra G; Franks B; Morgan G; Hebditch V; Jönsson B; Mabhala M; Reic T; Van Thiel I; Ratziu V; Romero-Gomez M; Bugianesi E; Schattenberg JM; Anstee QM
JHEP Rep; 2020 Oct; 2(5):100142. PubMed ID: 32775976
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review.
Kennedy-Martin T; Bae JP; Paczkowski R; Freeman E
J Patient Rep Outcomes; 2017; 2():28. PubMed ID: 29984351
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review.
Grønkjær LL; Lauridsen MM
JHEP Rep; 2021 Dec; 3(6):100370. PubMed ID: 34805816
[TBL] [Abstract][Full Text] [Related]
6. The burden of nonalcoholic steatohepatitis (NASH) in the United States.
Tapper EB; Krieger N; Przybysz R; Way N; Cai J; Zappe D; McKenna SJ; Wall G; Janssens N; Balp MM
BMC Gastroenterol; 2023 Apr; 23(1):109. PubMed ID: 37020273
[TBL] [Abstract][Full Text] [Related]
7. The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study.
Balp MM; Krieger N; Przybysz R; Way N; Cai J; Zappe D; McKenna SJ; Wall G; Janssens N; Tapper E
JHEP Rep; 2019 Sep; 1(3):154-161. PubMed ID: 32039365
[TBL] [Abstract][Full Text] [Related]
8. Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH.
Fishman J; Higgins V; Piercy J; Pike J
Health Qual Life Outcomes; 2023 Oct; 21(1):113. PubMed ID: 37838660
[TBL] [Abstract][Full Text] [Related]
9. Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study.
Doward LC; Balp MM; Twiss J; Slota C; Cryer D; Brass CA; Anstee QM; Sanyal AJ
Patient; 2021 Sep; 14(5):533-543. PubMed ID: 33336323
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Yamamura S; Nakano D; Hashida R; Tsutsumi T; Kawaguchi T; Okada M; Isoda H; Takahashi H; Matsuse H; Eguchi Y; Sumida Y; Nakajima A; Gerber L; Younossi ZM; Torimura T
J Gastroenterol Hepatol; 2021 Mar; 36(3):629-636. PubMed ID: 32627871
[TBL] [Abstract][Full Text] [Related]
11. Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.
Younossi ZM; Stepanova M; Noureddin M; Kowdley KV; Strasser SI; Kohli A; Ruane P; Shiffman ML; Sheikh A; Gunn N; Caldwell SH; Huss RS; Myers RP; Wai-Sun Wong V; Alkhouri N; Goodman Z; Loomba R
Hepatol Commun; 2021 Jul; 5(7):1201-1211. PubMed ID: 34278169
[TBL] [Abstract][Full Text] [Related]
12. The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review.
Witkowski M; Moreno SI; Fernandes J; Johansen P; Augusto M; Nair S
Pharmacoeconomics; 2022 Aug; 40(8):751-776. PubMed ID: 35789987
[TBL] [Abstract][Full Text] [Related]
13. Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
Alqahtani SA; Yilmaz Y; El-Kassas M; Alswat K; Sanai F; AlZahrani M; Abaalkhail F; AlShaikh M; Al-Hamoudi WK; Nader F; Stepanova M; Younossi ZM;
J Viral Hepat; 2024 Jun; 31(6):300-308. PubMed ID: 38622910
[TBL] [Abstract][Full Text] [Related]
14. Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
Younossi ZM; Stepanova M; Lawitz EJ; Reddy KR; Wai-Sun Wong V; Mangia A; Muir AJ; Jacobson I; Djedjos CS; Gaggar A; Myers RP; Younossi I; Nader F; Racila A
Am J Gastroenterol; 2019 Oct; 114(10):1636-1641. PubMed ID: 31464743
[TBL] [Abstract][Full Text] [Related]
15. The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.
Younossi ZM; Anstee QM; Wai-Sun Wong V; Trauner M; Lawitz EJ; Harrison SA; Camargo M; Kersey K; Subramanian GM; Myers RP; Stepanova M
Gastroenterology; 2021 Apr; 160(5):1608-1619.e13. PubMed ID: 33307033
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.
Holloway L; Humphrey L; Heron L; Pilling C; Kitchen H; Højbjerre L; Strandberg-Larsen M; Hansen BB
Health Qual Life Outcomes; 2014 Jul; 12():116. PubMed ID: 25048687
[TBL] [Abstract][Full Text] [Related]
17. Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Younossi ZM; Stepanova M; Anstee QM; Lawitz EJ; Wai-Sun Wong V; Romero-Gomez M; Kersey K; Li G; Subramanian GM; Myers RP; Djedjos CS; Okanoue T; Trauner M; Goodman Z; Harrison SA
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2552-2560.e10. PubMed ID: 30779990
[TBL] [Abstract][Full Text] [Related]
18. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
19. Humanistic and economic burden associated with depression in the United States: a cross-sectional survey analysis.
Jain S; Gupta S; Li VW; Suthoff E; Arnaud A
BMC Psychiatry; 2022 Aug; 22(1):542. PubMed ID: 35953786
[TBL] [Abstract][Full Text] [Related]
20. Health-related Quality of Life in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Multi-center UK Study.
Papatheodoridi M; Pallini G; Aithal G; Lim HK; Cobbold J; Plaz Torres MC; Misas MG; Ryan J; Tomlinson J; Allison M; Longworth L; Tsochatzis EA
Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3107-3114.e3. PubMed ID: 37880933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
